The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial

The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial

Abstract Background Patients with haematological malignancies often develop thrombocytopenia as a consequence of either their disease or its treatment. Platelet transfusions are commonly given to raise a low platelet count and reduce the risk of clinical bleeding (prophylaxis) or stop active bleedin...

Full description

Bibliographic Details
Main Authors: Lise J. Estcourt, Zoe McQuilten, Gillian Powter, Claire Dyer, Eleanor Curnow, Erica M. Wood, Simon J. Stanworth, on behalf of the TREATT Trial Collaboration (provisional)
Format: Article
Language:English
Published: BMC 2019-10-01
Series:Trials
Subjects:
Anti-fibrinolytic
Bleeding
Chemotherapy
Haematological malignancy
Haematopoietic stem cell transplant
Leukaemia
Online Access:http://link.springer.com/article/10.1186/s13063-019-3663-2

Internet

http://link.springer.com/article/10.1186/s13063-019-3663-2

Similar Items